Milademetan in Advanced/Metastatic Solid Tumors

NCT05012397 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

40

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor Decision

Conditions

Solid Tumors
Head and Neck Carcinoma
Cholangiocarcinoma
Sarcoma
Lung Adenocarcinoma
Bladder Urothelial Carcinoma
Stomach Adenocarcinoma
Breast Cancer Invasive
Ovarian Carcinoma
Cervical Cancer
Non Small Cell Lung Cancer
Gastric Cancer
Biliary Tract Cancer
Melanoma
Pancreas Cancer
MDM2 Gene Amplification
Testicular Germ Cell Tumor
Adrenocortical Carcinoma

Interventions

DRUG: RAIN-32

Sponsor

Rain Oncology Inc